Generalized Anxiety Disorder (GAD) affects millions of adults, often leading to persistent worry, restlessness, and difficulty concentrating. While current treatments—like SSRIs and talk therapy—can help, they don’t work for everyone. New research suggests that psychedelics may offer a novel path forward for those with treatment-resistant anxiety.
For many, it starts innocently enough — after an injury, a surgery, a moment of emotional overwhelm. A small prescription, a brief reprieve. But what was once a solution can, over time, become a cycle that’s difficult to break.
What if managing ADHD and anxiety didn’t mean juggling multiple daily pills or powering through therapies that never seem to fully connect? A growing number of researchers are asking the same question—and exploring new options that could better address the unique challenges of living with both conditions. For those who face constant distraction paired with relentless worry, this dual diagnosis can feel like a never-ending loop. But understanding the overlap may be the key to unlocking better care.
For millions living with Treatment-Resistant Depression (TRD), the usual approaches, therapy, antidepressants, or both, just aren’t enough. TRD is more than just “feeling down.” It’s a relentless condition where symptoms persist despite multiple treatment attempts, leaving people stuck in cycles of medication changes, side effects, and frustration.
Living with schizophrenia isn’t just about managing symptoms, it’s about navigating a reality that can feel unpredictable and isolating. Whether you're personally affected or supporting someone who is, understanding this condition is the first step toward finding stability and hope. From sudden psychotic episodes to long-term challenges with thinking and motivation, schizophrenia affects every part of life, but new research is bringing fresh insights and potential breakthroughs.
What if anxiety care didn’t mean taking a pill every day or endlessly pushing through talk therapy that doesn’t quite stick? A growing number of researchers are asking that same question—and turning their attention to a new possibility: psychedelic-assisted therapy. Currently under investigation in advanced clinical trials, this approach combines guided psychedelic sessions with therapeutic support to explore how it may impact people living with chronic anxiety.
What if one or two supervised sessions with a psychedelic compound could help people with depression feel relief faster—and with longer-lasting effects—than traditional medications?
Everyone feels down from time to time. But when sadness, hopelessness, and lack of interest in life persist for weeks or months, it may be more than just a rough patch—it could be Major Depressive Disorder (MDD).
Living with ADHD can be a daily challenge — disorganization, impulsivity, forgetfulness, and difficulty staying focused can disrupt work, school, and relationships. But for many, these symptoms are only part of the picture. Anxiety disorders frequently co-occur with ADHD, adding another layer of complexity to daily life.
For many, depression is an invisible battle — a daily weight that colors every thought, decision, and moment. While some find relief through therapy or antidepressants, others continue to struggle despite trying multiple medications. This is known as treatment-resistant depression (TRD), and it affects a significant number of people diagnosed with Major Depressive Disorder (MDD).